Tamoxifen-induced enteroendocrine cell depletion in adult male Neurog3fl/fl;Villin-CreERT2 mice causes impaired lipid absorption, weight loss, and rapid gut microbiota remodeling on a standard chow diet.
Cellular and Molecular Gastroenterology and Hepatology · 12 authors, 10 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Tamoxifen-induced enteroendocrine cell depletion in adult male Neurog3fl/fl;Villin-CreERT2 mice causes impaired lipid absorption, weight loss, and rapid gut microbiota remodeling on a standard chow diet.
Adult male Neurog3fl/fl;Villin-CreERT2 mice were treated with tamoxifen to deplete intestinal enteroendocrine cells, and energy metabolism, intestinal transcriptome, and microbiota were assessed. Under a standard chow diet, EEC-deficient mice lost 10% of body weight due to impaired food efficiency, with reduced blood cholesterol, triglycerides, and free fatty acids. Lipid absorption was impaired and spatially delayed in the distal small intestine. Transcriptomic profiling revealed upregulation of lipogenesis, carbohydrate metabolism, and neoglucogenesis genes in the ileum. Microbiota composition was rapidly altered, with decreased alpha-diversity, progressive enrichment of Bacteroides and Lactobacillus, and decline of Lachnospiraceae, without changes in fecal short-chain fatty acid concentrations. All experiments were performed in males, precluding conclusions about female mice. The study identifies compensatory metabolic and transcriptomic adaptations to sustained lipid malabsorption in adults, a phenomenon not previously studied due to neonatal lethality of constitutive EEC deficiency.